AstraZeneca Pharma India today posted net profit of Rs 1.76 crore for the first quarter ended June 30, 2013.
The company had posted net loss of Rs 8.14 crore during the April-June period of 2012-13 fiscal.
Net sales during Q1, 2013-14 rose to Rs 125.13 crore, compared to Rs 91.26 crore in the year-ago period, AstraZeneca Pharma said in a filing to the BSE.
The company’s scrip closed at Rs 738.15, up 4.72 per cent, on the BSE.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.